SCHEMBL419872

SCHEMBL419872

CCCNC(C)(C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11109530 0.97 HTT (0.37)
SCHEMBL9638094 0.85 HTT (0.38)
Nitric Acid SCHEMBL10792262 0.85 HTR1A (0.35)
SCHEMBL2114006 0.84 TSHR (0.36)
SCHEMBL28088912 0.82 ALDH1A1 (0.42)
SCHEMBL27705462 0.80 EPHX1 (0.44)
SCHEMBL11767372 0.80 EPHX1 (0.44)
SCHEMBL12927516 0.80 HTT (0.35)
SCHEMBL1457911 0.80
SCHEMBL4782050 0.80 HTT (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9879025-B2 Transfer hydrogenation of cyclopamine analogs INFINITY PHARMACEUTICALS, INC. (US) 2018-01-30 US disclosed
US-20170029433-A1 TRANSFER HYDROGENATION OF CYCLOPAMINE ANALOGS ROYALTY SECURITY, LLC 2017-02-02 US disclosed
US-20170029433-A1 TRANSFER HYDROGENATION OF CYCLOPAMINE ANALOGS ROYALTY SECURITY, LLC 2017-02-02 US disclosed
US-9394313-B2 Transfer hydrogenation of cyclopamine analogs INFINITY PHARMACEUTICALS, INC. (US) 2016-07-19 US disclosed
US-9376447-B2 Transfer hydrogenation of cyclopamine analogs INFINITY PHARMACEUTICALS, INC. (US) 2016-06-28 US disclosed
US-20130045963-A1 Cyclohexyl Azetidine Derivatives as JAK Inhibitors INCYTE CORPORATION (US) 2013-02-21 US disclosed
US-20120065400-A1 Transfer Hydrogenation of Cyclopamine Analogs INFINITY PHARMACEUTICALS, INC. (US) 2012-03-15 US disclosed
US-20120065399-A1 Transfer Hydrogenation of Cyclopamine Analogs INFINITY PHARMACEUTICALS, INC. (US) 2012-03-15 US disclosed
EP-0705637-B1 Process for removing carbon dioxide from gases KANSAI ELECTRIC POWER CO (JP) 2001-09-19 EP disclosed
US-3961117-A Antistatic carpet and method for manufacturing same HERCULITE PROTECTIVE FABRICS CORPORATION (US) 1976-06-01 US disclosed